
==== Front
Infect Med (Beijing)
Infect Med (Beijing)
Infectious Medicine
2097-0684
2772-431X
Elsevier

S2772-431X(24)00040-6
10.1016/j.imj.2024.100126
100126
Short Communication
Evaluating the performance of the Alere PBP2a SA Culture Colony Test with the Vitek 2 Antimicrobial Susceptibility Test Card System as reference standard in coagulase-negative Staphylococcus species
Lo Tze Shien tze.lo@va.gov
ab⁎
Goto Michihiko cd
Hammer Kimberly D.P. ab
a Fargo VA Health Care System, 2101 Elm Street, Fargo, ND 58102, USA
b University of North Dakota School of Medicine & Health Sciences, 1919 Elm Street, Fargo, ND 58102, USA
c Iowa City VA Health Care System, 601 Highway 6 West, Iowa City, IA 52246, USA
d University of Iowa Carver College of Medicine, 451 Newton Road, Iowa City, IA 52242, USA
⁎ Corresponding author: Fargo VA Health Care System, 2101 Elm Street, Fargo, ND 58102, USA. tze.lo@va.gov
06 8 2024
9 2024
06 8 2024
3 3 1001266 12 2023
8 2 2024
23 2 2024
© 2024 The Author(s)
2024
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Highlights

• The PBP2a immunochromatographic (IC) assay was 66.7% sensitive and 100% specific for Staphylococcus epidermidis compared to microdilution minimum inhibitory concentration method.

• The PBP2a assay is 100% sensitive and specific in predicting the susceptibility of non-epidermidis CoNS.

• A larger number of isolates is needed to confirm our findings of high accuracy in predicting the susceptibility of non-epidermidis CoNS by PBP2a IC assay.

Background

The Alere PBP2a SA Culture Colony Test is an FDA-cleared in vitro immunochromatographic assay for rapid detection of penicillin-binding protein2a (PBP2a) in Staphylococcus aureus.

Methods

We investigated the performance of the PBP2a SA Culture Colony Test with 78 coagulase-negative Staphylococcus (CoNS) isolates from different body sites, with the Vitek 2 Antimicrobial Susceptibility Test (AST) as a reference standard.

Results

The CoNS species were 62 S. epidermidis; 6 S. lugdenensis; 3 S. hominis; 2 S. capitis; 2 S. haemolyticus; and 1 each of S. simulans, S. auricularis, and S. warneri. Of the 78 CoNS isolates, 68 showed concordance in the PBP2a IC assay and Vitek 2 AST. Discordance was seen for 10 S. epidermidis isolates, which showed negative in the PBP2a assay, despite oxacillin-resistance detection using the Vitek 2 AST (66.7% sensitivity and 100% specificity). All non-S. epidermidis CoNS were identified with 100% concordance using the PBP2a IC assay and Vitek 2 AST.

Conclusion

We demonstrated that, while the PBP2a IC assay has low sensitivity in determining the susceptibility of S. epidermidis to oxacillin, it highly accurately predicted the susceptibility of non-S. epidermidis CoNS to oxacillin. The diagnostic accuracy for non-S. epidermidis CoNS needs further assessment with more isolates to confirm our findings.

Graphical abstract

Image, graphical abstract

Keywords

PBP2a IC assay
Staphylococcus epidermidis
Non-epidermidis coagulase-negative Staphylococcus
Abbreviations

PBP2a penicillin-binding protein2a

CoNS coagulase-negative Staphylococcus

AST Antimicrobial Susceptibility Test

MRSA methicillin-resistant Staphylococcus aureus

BMMICM broth microdilution minimum inhibitory concentration method

IC immunochromatographic
==== Body
pmc1 Background

The main hallmark of methicillin-resistant Staphylococcus aureus (MRSA) is the possession of the mecA gene, which produces penicillin-binding protein 2a (PBP2a). This confers resistance to beta-lactam agents, except for the fifth-generation cephalosporins ceftaroline and ceftobiprole.

The Alere PBP2a SA Culture Colony Test (Alere Scarborough, Inc., Scarborough, ME, USA) is an FDA-cleared, simple, qualitative, in vitro immunochromatographic (IC) assay that uses monoclonal antibodies for the rapid detection of PBP2a in S. aureus isolates. The test uses very sensitive recombinant monoclonal antibody fragments (rFabs) to detect the PBP2a protein from S. aureus. The clinical performance of the PBP2a IC test was compared with cefoxitin disk diffusion in S aureus isolates and showed a sensitivity of 99.1% and specificity of 99.2% on tryptic soy agar plates [1].

Because it takes about 5 minutes to identify whether an S. aureus isolate is MRSA without using an expensive high-tech machine, Fargo VA Healthcare System, an 80-bed Veterans Affairs Hospital in Fargo, North Dakota, has been using the PBP 2a IC test to rapidly identify MRSA from S. aureus clinical isolates. This has routinely been confirmed with the Vitek 2 Antimicrobial Susceptibility Test (AST) reference standard since August 2011.

2 Methods

Most coagulase-negative Staphylococcus (CoNS) species also possess the mecA gene; however, only a few studies have investigated the diagnostic performance of IC assays that target the PBP2a of CoNS [2,3]. The aim of this study was to validate the performance of the PBP2a IC test for clinically significant CoNS isolates using the Vitek 2 AST Card System (BioMérieuex, Inc., Durham, NC, USA) based on the broth microdilution minimum inhibitory concentration method (BMMICM) as a reference standard.

Eighty clinical CoNS isolates at Fargo VA Healthcare System that met the inclusion criteria were tested with the Alere PBP2a SA Colony Test, and the results were compared with those of Vitek 2 AST, from October 2014 to September 2016. The criteria for including CoNS clinical isolates in this study were positive blood culture of ≥ 2 sets; positive urine culture of ≥ 105 CFU/mL of pure CoNS; positive wound culture of pure CoNS; and positive abdominal, pleural, and synovial fluid culture. These isolates were included because they were considered clinically significant based on American Society for Microbiology (ASM) recommendations [4]. Exclusion criteria were a positive blood culture of only one set, positive urine culture of <105 CFU/mL, and positive urine culture of ≥ 105 CFU/mL, but not pure CoNS or wound cultures that grew a CoNS isolate as one of the polymicrobial flora.

To verify the accuracy and examine the performance of the PBP2a SA Culture Colony Test, we randomly selected 60 S. aureus isolates, with Vitek 2 AST as the reference standard, before commencing the coagulase-negative Staphylococcus study. Both the PBP2a SA Culture Colony Test and Vitek 2 AST were performed according to the manufacturers’ instructions.

This study was approved by the University of South Dakota's Institutional Review Board and the Fargo VA Health Care System's Research and Development committee.

3 Results

The 60 S. aureus isolates selected randomly as controls demonstrated 100% concordance between the PBP2a IC assay and Vitek 2 AST.

Eighty CoNS isolates from 80 unique patients were studied, and 2 samples were excluded owing to the failure of the Vitek 2 machine to perform the oxacillin minimal inhibitory concentration (MIC) test. Staphylococcus epidermidis accounted for 80% of the 78 CoNS isolates that were included for analysis (n = 62), followed by S. lugdenensis (n = 6), S. hominis (n = 3), S. capitis (n = 2), S. haemolyticus (n = 2), S. simulans (n = 1), S. auricularis (n = 1), and S. warneri (n = 1).

A breakdown of the sources and species of the 78 coagulase-negative Staphylococcus isolates is shown in Table 1. Because the primary objective of this study was to solely investigate the performance of the PBP2a SA Culture Colony Test for CoNS isolates, we did not look into the clinical implications of our microbiological findings.Table 1 Sources and species of the 78 coagulase-negative Staphylococcus isolates.

Table 1Source	Species	Number of samples	
Urine	S. epidermidis	44	
	S. hominis	2	
	S. lugdunensis	1	
	S. haemolyticus	1	
	S. warneri	1	
Wound	S. epidermidis	15	
	S. lugdunensis	4	
	S. auricularis	1	
	S. simulans	1	
	S. capitis	1	
Blood	S. capitis	1	
	S. haemolyticus	1	
	S. hominis	1	
Synovial fluid	S. epidermidis	1	
	S. lugdunensis	1	
Pleural fluid	S. epidermidis	1	
Abdominal fluid	S. epidermidis	1	

There was concordance for 68 CoNS isolates between the PBP2a IC assay and the Vitek 2 AST. However, there was discordance for 10 S. epidermidis isolates, which showed as negative on the PBP2a assay, despite oxacillin resistance (MIC >4 µg/mL) showing on the Vitek 2 AST. A breakdown of the sources of the 10 S. epidermidis isolates is as follows: 7 from urine, 2 from wounds, and 1 from abdominal fluid. There was 100% concordance between the PBP2a IC assay and Vitek 2 AST for all non-epidermidis CoNS isolates.

The overall performance of the PBP2a IC assay was 66.7% sensitivity and 100% specificity for S. epidermidis when using the broth microdilution minimum inhibitory concentration method (BMMICM) as a reference standard (Table 2). The positive predictive value was 100%, the negative predictive value was 76.2%, and the prevalence of oxacillin-resistant isolates was 48%.Table 2 2×2 table of PBP2a and oxacillin results for the 62 Staphylococcus epidermidis isolates.

Table 2Total Isolates 62	Oxacillin Resistant 30	Oxacillin Sensitive 32	
PBP2a positive 20	20	0	
PBP2a negative 42	10	32	

4 Discussion and conclusion

Our study showed that the concordance rate between the PBP2a IC assay and BMMICM was 100% for Staphylococcus aureus and non-S. epidermidis coagulase-negative Staphylococcus. However, the IC assay failed to detect oxacillin resistance in 10 (33%) of the S. epidermidis isolates that showed oxacillin resistance by BMMICM. Two studies, one conducted in Japan and the other in France, found that an immunochromatographic assay for detecting PBP2a among non-Staphylococcus aureus isolates was 100% accurate. The smaller sample numbers of coagulase-negative Staphylococcus isolates in Matsui et al.’s and Mantion et al.’s studies (n = 53 and 25, respectively) might explain why both studies were unable to detect any difference between the two methodologies [5,6]. Another study conducted by Arnold and colleagues found that the Alere PBP2a culture colony test was sensitive and specific for non-aureus Staphylococcus species, but the studied isolates did not include S. epidermidis [7].

A recent study demonstrated that the methicillin-resistant isolates of CoNS that initially showed as negative in the IC assay could be induced to show as positive by harvesting colonies from around the cefoxitin disk (cefoxitin induction) [3]. We did not perform cefoxitin induction in our study and that might explain the high negative PBP2a rate among the oxacillin-resistant isolates. Another plausible explanation for the discordance between the PBP2a IC assay and BMMICM in our study is the heterogenous expression of the mecA gene by various species of CoNS [8,9]. Suzuki and co-workers showed that CoNS can manifest oxacillin resistance via mechanisms other than the production of PBP2a [10].

In conclusion, our study demonstrated that the PBP2a IC assay has low sensitivity in determining the susceptibility of S. epidermidis to oxacillin. In contrast, the assay is highly accurate in predicting the susceptibility of non-epidermidis CoNS to oxacillin. However, because of the small sample size, the diagnostic accuracy for non-epidermidis CoNS needs further assessment with a larger number of isolates to confirm our findings.

This study was the result of work performed at the Fargo VA Health Care System and supported with resources and the use of the Health Care System's facilities. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.

CRediT authorship contribution statement

Tze Shien Lo: Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing. Michihiko Goto: Formal analysis, Writing – original draft, Writing – review & editing. Kimberly D.P. Hammer: Formal analysis, Writing – original draft, Writing – review & editing.

Funding

The authors did not receive any funding support for this study.

Acknowledgments

This study is the result of work performed at the Fargo VA Health Care System and supported with resources and the use of the Health Care System facilities. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.

We thank the lab technologists Debra Ankeney, MT (ASCP) and Kirsten Orvik, MT (ASCP) for their assistance in testing the isolates.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Data available statement

Data sharing not applicable—no new data generated. We used existing data available through the VA Corporate Date Warehouse.

Ethics statements

This study was approved by the VA affiliate Institutional Review Board and the VA Research & Development Committee.

Informed consent

Waiver of informed consent was granted by the Institutional Review Board.
==== Refs
References

1 Alere PBP2a SA Culture Colony Test Product Insert, 2015. Available at: https://www.fishersci.com/shop/products/alere-pbp2a-test-kit-alere-pbp2a-test/23029989. Accessed July 7, 2020.
2 Dhiman N. Trienski T.L. DiPersio L.P. Evaluation of the BinaxNOW Staphylococcus aureus test for rapid identification of Gram-positive cocci from VersaTREK blood culture bottles J. Clin. Microbiol. 51 9 2013 2939 2942 10.1128/JCM.01087-13 23804393
3 Dupieux C. Trouillet-Assant S. Tasse J. Evaluation of a commercial immunochromatographic assay for rapid routine identification of PBP2a-positive Staphylococcus aureus and coagulase-negative staphylococci Diagn. Microbiol. Infect. Dis. 86 3 2016 262 264 10.1016/j.diagmicrobio.2016.08.012 27608539
4 Leber A.L. Clinical Microbiology Procedures Handbook 4th ed. 2016 ASM Press Washington DC
5 Matsui H. Hanaki H. Inoue M. Development of an immunochromatographic strip for simple detection of penicillin-binding protein 2′ Clin. Vaccine Immunol. 18 2 2011 248 253 10.1128/CVI.00252-10 21177917
6 Mantion B. Cavalié L. Prère M.F. Evaluation of an immunochromatographic assay for detection of PBP2a on non-Staphylococcus aureus clinical isolates J. Microbiol. Meth. 112 2015 46 48 10.1016/j.mimet.2015.02.014
7 Arnold A.R. Burnham C.A D. Ford B.A. Evaluation of an immunochromatographic assay for rapid detection of penicillin-binding protein 2a in human and animal Staphylococcus intermedius group, Staphylococcus lugdunensis, and Staphylococcus schleiferi clinical isolates J. Clin. Microbiol. 54 3 2016 745 748 10.1128/JCM.02869-15 26677248
8 Hackbarth C.J. Chambers H.F. Methicillin-resistant staphylococci: genetics and mechanisms of resistance Antimicrob. Agents Chemother. 33 7 1989 991 994 10.1128/AAC.33.7.991 2675759
9 Archer G.L. Climo M.W. Antimicrobial susceptibility of coagulase-negative staphylococci Antimicrob. Agents Chemother. 38 10 1994 2231 2237 10.1128/AAC.38.10.2231 7840550
10 Suzuki E. Hiramatsu K. Yokota T. Survey of methicillin-resistant clinical strains of coagulase-negative staphylococci for mecA gene distribution Antimicrob. Agents Chemother. 36 2 1992 429 434 10.1128/AAC.36.2.429 1605606
